Skip to content
Parakho

Windlas Biotech Ltd

NSE WINDLASBSE 543329windlas.com

Q4 FY26

Revenue
₹238.50 Cr
Profit after tax
₹15.99 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ4 FY26vs a year agoFY26
Revenue from operations238.50—904.09
Other income4.35—17.80
Total income242.85—921.89
Employee benefit expense41.37—152.09
Finance costs1.48—4.83
Depreciation & amortisation8.00—30.74
Total expenses222.69—834.92
Profit before tax20.16—86.98
Tax expense4.17—20.52
Profit after tax15.99—66.46
Total comprehensive income16.07—66.57
Earnings per share
Earnings per share, basic₹7.58₹31.60
Earnings per share, diluted₹7.49₹31.15

Q4 FY26 and FY26 — from the company’s filing with NSE. Source

Why the dash

Parakho has not ingested this company’s year-ago quarter, so the change column stays empty. A dash means we do not hold the figure — never that it is zero.

Earnings call

Q4 FY26

Windlas Biotech reported FY26 revenue of INR904 crores, up 19% year-on-year, with Q4 FY26 revenue at INR238 crores, up 18% year-on-year, marking 13 consecutive quarters of record revenue. Management attributed growth to the CDMO vertical, which grew 20% year-on-year, while the Trade Generics and Institutional vertical faced softness from the exit of codeine-based cough syrups. The company also reported completion of a buyback, a proposed dividend, and progress on Plant 6, which reached mechanical completion and is expected to commercialize in H1 FY27.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 50 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 14 Aug 2026.